Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Charles River Laboratories Intl (NY: CRL )

228.90 -0.10 (-0.04%)
Streaming Delayed Price Updated: 9:50 AM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Charles River Laboratories Intl

< Previous 1 2 3 4 Next >
Evaluating Charles River: Insights From 7 Financial Analysts
Via Benzinga
The Top 3 Healthcare Stocks to Buy in March 2024
There are still bargains to be had in the medical space. These are three top healthcare stocks to buy today. 
Via InvestorPlace
Betting on Bitcoin: Does Coinbase Stock’s Surge Signal a Buy?
vBitcoin has exploded higher over the past month setting an all-time record. That’s excellent news for Coinbase Global and COIN stock. 
Via InvestorPlace
Thermo Fisher Stock Lights Up The Board, Soars 40% In 5 Months
Thermo Fisher stock has risen more than 40% since October. Additionally, it's closed higher nine of the past 11 trading sessions. 
Via Investor's Business Daily
The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.
Looking for the next generational winner in healthcare stocks? These are three of the top prospects today. 
Via InvestorPlace
Forecasting The Future: 4 Analyst Projections For Charles River
Via Benzinga
Earnings Scheduled For February 14, 2024
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion. 
Via Benzinga
9 Analysts Have This to Say About Charles River
Via Benzinga
Expert Ratings for Charles River
Via Benzinga
Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What's Driving Markets Wednesday?
The U.S. stock market attempted a rebound following Tuesday’s declines, which were sparked by a higher-than-expected inflation report in January, as investors refocused on corporate earnings. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Charles River Laboratories Stock Surges On Upbeat Annual Outlook, But This Analyst Is Concerned
Charles River Laboratories Q4 2023 revenue: $1.01 billion, down 7.9% YoY, beating consensus. Analysts note mixed Q4 performance, keeping Outperform rating. 
Via Benzinga
Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
8 Analysts Have This to Say About Charles River
Via Benzinga
What 5 Analyst Ratings Have To Say About Charles River
Via Benzinga
Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list... 
Via Benzinga
Ten Big Losers To Start The Year. Tesla Isn't The Worst.
Enphase Energy remains out of phase with the stock market. 
Via Investor's Business Daily
Investing in the Aging Population: 3 Healthcare Stocks to Watch
America is becoming a much older country on average. These three healthcare stocks are ideally positioned for this demographic shift. 
Via InvestorPlace
The 3 Most Undervalued Tech Stocks to Buy Now: November 2023
Growth stocks are rallying but there are still bargains to be found. These three top tech picks can reward long-term investors. 
Via InvestorPlace
Charles River Labs Q3 Revenue Jumps 4% Despite Softer Client Spending, Narrows Outlook
Charles River Laboratories International Inc (NYSE: CRL) reported third-quarter (Q3) sales of $1.03 billion, an increase of 3.8% Y/Y, beating the  
Via Benzinga
Q4 Stock Predictions: 3 S&P 500 Stocks Ready to Soar
S&P 500 stocks are sliding amid a worrying interest rate environment. However, these three can buck the current downtrend. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday. 
Via Benzinga
Steer Clear of Outrageously Valued VinFast Stock. 3 EV Stocks to Buy Instead.
VinFast stock has gotten inflated since its blank-check merger in early August. Check out these three EV stocks instead. 
Via InvestorPlace
WeWork's Journey From $47B Valuation To Possible Bankruptcy, Mastercard and Visa Reassess Ties with Binance Card, Hawaiian Electric Accused Of Jeopardizing Investigation Of Maui Wildfires: Today's Top Stories
Wall Street Journal 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Endangered Horseshoe Crabs Vital In Medical Research, Charles River Lab Commits To Enhanced Protection
Charles River Laboratories International Inc (NYSE: CRL) has joined hands with four significant entities in a pioneering move to amplify protections for the horseshoe crabs and the red knots bird... 
Via Benzinga
B of A Securities Maintains Buy Rating for Charles River: Here's What You Need To Know
Via Benzinga
US Stocks Edge Lower; Charles River Earnings Top Estimates
U.S. stocks were mostly lower this morning, with the Nasdaq Composite falling more than 50 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.03% to 35,303.64 while the... 
Via Benzinga
Lyft, Disney And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Investor Sentiment Declines After Moody's Downgrades Credit Ratings Of Banks
The CNN Money Fear and Greed index showed a decline in overall sentiment among U.S. investors on Tuesday. U.S. stocks closed lower on Tuesday after Moody's downgraded the credit ratings of several US... 
Via Benzinga
Buy Alert: 3 Healthcare Stocks Nearing Super Attractive Entry Points
Explore the resilience of healthcare stocks that are demonstrating signs of recovery, with robust long-term growth potential ahead. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2023
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.